EPIQ Capital Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-86,291
| Closed | -$224K | – | 80 |
|
|
2024
Q3 | $224K | Hold |
86,291
| – | – | 0.06% | 64 |
|
|
2024
Q2 | $255K | Hold |
86,291
| – | – | 0.09% | 54 |
|
|
2024
Q1 | $391K | Hold |
86,291
| – | – | 0.16% | 39 |
|
|
2023
Q4 | $493K | Hold |
86,291
| – | – | 0.22% | 28 |
|
|
2023
Q3 | $397K | Hold |
86,291
| – | – | 0.21% | 33 |
|
|
2023
Q2 | $557K | Hold |
86,291
| – | – | 0.28% | 26 |
|
|
2023
Q1 | $651K | Hold |
86,291
| – | – | 0.33% | 22 |
|
|
2022
Q4 | $874K | Hold |
86,291
| – | – | 0.48% | 18 |
|
|
2022
Q3 | $853K | Sell |
86,291
-23,756
| -22% | -$235K | 0.42% | 19 |
|
|
2022
Q2 | $1.17M | Buy |
110,047
+18,847
| +21% | +$201K | 0.46% | 20 |
|
|
2022
Q1 | $889K | Sell |
91,200
-1,158
| -1% | -$11.3K | 0.24% | 25 |
|
|
2021
Q4 | $1.32M | Sell |
92,358
-50,612
| -35% | -$724K | 0.23% | 24 |
|
|
2021
Q3 | $2.87M | Buy |
+142,970
| New | +$2.87M | 0.3% | 16 |
|